Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Chiara Sartor

11PUBLICATIONS
49CO-AUTHORS
Predictive and prognostic markersHaematological tumoursHaematologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Regenerative medicine (incl. stem cells)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

Sort by Publication Date:
|Jun 11, 2026
A dynamic prognostic model for Polycythemia Vera long-terms outcomes in patients treated with Ruxolitinib.

|Feb 13, 2025
Emergence and Cytogenetic Clonal Evolution of Chromosome 7 Abnormalities in Myeloid Malignancies: Investigating the Role of Telomere Dysfunction.

Carmen Baldazzi, Lorenza Bandini, Valentina Robustelli

|Jul 27, 2024
Impact of Anti-CD38 Monoclonal Antibody Therapy on CD34+ Hematopoietic Stem Cell Mobilization, Collection, and Engraftment in Multiple Myeloma Patients-A Systematic Review.

Flavia Bigi, Enrica Manzato, Simona Barbato

|Jun 19, 2024
Ponatinib as a Prophylactic or Pre-Emptive Strategy to Prevent Cytological Relapse after Allogeneic Stem Cell Transplantation in Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Transplanted in Complete Cytological Remission.

Anna Candoni, Patrizia Chiusolo, Davide Lazzarotto

|Sep 28, 2023
Blinatumomab and Inotuzumab Ozogamicin Sequential Use for the Treatment of Relapsed/Refractory Acute Lymphoblastic Leukemia: A Real-Life Campus All Study.

Nicola Stefano Fracchiolla, Mariarita Sciumè, Cristina Papayannidis

|May 25, 2023
A venetoclax and azacitidine bridge-to-transplant strategy for NPM1-mutated acute myeloid leukaemia in molecular failure.

C Sartor, L Brunetti, E Audisio

Pageof 2

Frequent Collaborators

3 joint publications

Cristina Papayannidis

3 joint publications

Giovanni Marconi

2 joint publications

Simona Soverini

2 joint publications

Davide Lazzarotto

2 joint publications

Nicola Stefano Fracchiolla

1 joint publications

A Curti

1 joint publications

Federica Sorà

1 joint publications

Francesco Albano

1 joint publications

Filippo Branzanti

1 joint publications

Simone Ragaini

Frequent Collaborators

3 joint publications

Cristina Papayannidis

3 joint publications

Giovanni Marconi

2 joint publications

Simona Soverini

2 joint publications

Davide Lazzarotto